Mind Cure has listed the warrants for trading from its recent financing. Warrants are valid until February 10, 2026, at an exercise price of CAD$0.80.
Articles
264 Million Reasons Psychedelic Stocks Have More Room to Grow
There is big money to be made from psychedelic stocks and the companies planning to treat depression will be the winners.
Colorado Has Sold $10 Billion Worth Of Legal Weed Since 2014
Colorado cannabis retailers have sold more than $10 billion worth of legal pot since recreational marijuana became legal in the state in 2014, with more than $2 billion of that total coming in 2020 alone.
Countdown to Psychedelic Stock Rally, Part 2: Sector-Wide Catalysts
A number of potential sector-wide catalysts for psychedelic stocks are already present or rapidly approaching.
Iowa GOP Lawmaker Makes Another Push To Decriminalize Psilocybin Mushrooms
A Republican lawmaker in Iowa is taking another swing at reforming the state’s psychedelics laws, introducing a bill on Tuesday to remove psilocybin from the list of controlled substances.
Leviathan Gold Goes Public on TSXV Under Symbol LVX
Spinoff of Fosterville South
Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option
Mind Cure closes on a CAD$23 million bought deal financing, after the full over-allotment was exercised.
West Virginia House GOP Leader Polls Colleagues On Marijuana Legalization As Revenue Booster
A West Virginia House leader recently circulated an internal poll among Republican lawmakers, inquiring about what kind of policies—including marijuana legalization—they’d be willing to support to increase revenue to the state as part of a plan to eliminate the personal income tax.
New Mexico Marijuana Legalization Bills Get First Hearing This Week
As the governor of New Mexico steps up her push to enact marijuana legalization, a House committee is set to take up two separate proposals to end cannabis prohibition at a hearing this weekend.
Countdown to Psychedelic Stock Rally, Part 1: Individual Drivers
After a torrid rally near the end of 2020, psychedelic drug stocks have been in a holding pattern. Here is why lift-off could occur at any time.
Connecticut Governor’s Marijuana Task Force Issues Social Equity Recommendations For Legalization
An informal task force formed by Connecticut Gov. Ned Lamont (D) has issued a series of recommendations on how to legalize marijuana with an eye toward social justice for communities most harmed by prohibition.
Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica
Field Trip opens a psychedelic research facility in Jamaica, in partnership with University of the West Indies.
Magic mushrooms: How long do they stay in your system?
Magic mushrooms, or “shrooms,” are a type of mushroom containing psilocybin, a hallucinogenic compound.
Psychedelic Drug DMT To Be Trialed On Stroke Victims
Researchers are to begin trialing the use of the psychedelic drug DMT as a treatment for stroke patients, after preclinical studies on rats indicated that the substance could help the brain repair itself following injury.
New nonprofit aims to advise on creation of Oregon’s psilocybin-assisted therapy system
The people who brought psilocybin-assisted therapy to Oregon have created a new nonprofit to make sure the spirit of the ballot measure is preserved as state officials turn the voter-approved initiative into official policy.